StemCell Therapy

At Animal Medical Centers of Loudoun, we understand the deep bond you share with your furry family members. We all know what its like to have pets as part of our own families, and the patients and owners who visit our clinic become like our second family. Our mission is to support you and your pet through every stage of life. When pets approach the end of their lives or require palliative care, were committed to helping our patients and their families with the utmost care, compassion, and respect.

Our team is composed of highly-trained and compassionate veterinarians, technicians, and support staff who are dedicated to ensuring your pet's end-of-life experience is as peaceful and painless as possible. We are proud to have experts in palliative care and hospice, which allows us to tailor our services to meet the unique needs of each individual pet.

Pain management and care for late-stage conditions can help to maintain your pets quality of life for as long as possible. Your veterinarian can also work with you to create an at-home care plan so your pet remains in the comfort of familiar surroundings while still receiving supportive care. If your pet requires hospice care or you choose euthanasia in a medically-necessary situation, our staff will help you ensure that your pet is safe and comforted in their final moments.

Saying goodbye to a beloved pet is incredibly difficult, and we understand the profound grief that can accompany that loss. Were here to offer unwavering support and help you navigate this difficult time. We can provide resources to help you honor your pets memory, such as cremation services and customized urns and memorials.

If you have any questions or would like to discuss your pet's end-of-life needs, please don't hesitate to reach out.

Continued here:
Compassionate End-of-Life Care for Pets | Animal Medical Center of Loudoun

Hormone Hassle: Managing Addisons Disease In Pets  Texas A&M University Today

Visit link:
Hormone Hassle: Managing Addisons Disease In Pets - Texas A&M University Today

Proposition 129 is a dangerous step backward for veterinary care  The Fence Post

Read more:
Proposition 129 is a dangerous step backward for veterinary care - The Fence Post

Prop 129 introduces a new position to veterinary care  KJCT

More:
Prop 129 introduces a new position to veterinary care - KJCT

Managing seizures in dogs and cats  DVM 360

Read the rest here:
Managing seizures in dogs and cats - DVM 360

Why Are Cats So Flexible? This Body Part Is Key  Inverse

Follow this link:
Why Are Cats So Flexible? This Body Part Is Key - Inverse

Those pets need the same care as our dogs and cats: New Bluefield vet treats exotic animals  WVVA

Continued here:
Those pets need the same care as our dogs and cats: New Bluefield vet treats exotic animals - WVVA

Letter to the editor: As a veterinarian, I urge you to vote no on Prop 129  Summit Daily

See the article here:
Letter to the editor: As a veterinarian, I urge you to vote no on Prop 129 - Summit Daily

Weatherford vet among four appointed to state board  Weatherford Democrat

Continue reading here:
Weatherford vet among four appointed to state board - Weatherford Democrat

The Vets and BetterVet Merge to Revolutionize Pet Care with Nationwide At-Home Services  Vet Candy

Continued here:
The Vets and BetterVet Merge to Revolutionize Pet Care with Nationwide At-Home Services - Vet Candy

Struggling with high pet med costs? Canada's competition watchdog calls for more choice and affordable options  CBC.ca

Link:
Struggling with high pet med costs? Canada's competition watchdog calls for more choice and affordable options - CBC.ca

Guest opinion: Kerry Madole: Prop 129 will help us move towards ensuring all animals receive the care they need  Boulder Daily Camera

Read the original post:
Guest opinion: Kerry Madole: Prop 129 will help us move towards ensuring all animals receive the care they need - Boulder Daily Camera

This Auburn grad found an amazing alternative to vet school in Huntsville  Hville Blast

Read the original here:
This Auburn grad found an amazing alternative to vet school in Huntsville - Hville Blast

What Is Colorados Proposition 129? Here is Everything You Need to Know  Teekinship

Excerpt from:
What Is Colorados Proposition 129? Here is Everything You Need to Know - Teekinship

Schlieren / Zurich, Switzerland, 1 November, 2024 – Memo Therapeutics AG (or “MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, announces today that the last patient has been enrolled in its 22-site U.S. Phase II trial for its BK polyomavirus (“BKV”)-neutralizing antibody, potravitug.

Go here to see the original:
Memo Therapeutics AG Announces Last Patient Enrolled in Phase II Clinical Trial of Potravitug for Treatment of BK Viremia in Kidney Transplant...

DURHAM, N.C., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 7, 2024 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2024, and to provide a business overview.

More:
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024

SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that the company's third quarter 2024 financial results will be released after market close on Thursday, November 7, 2024. Skye will host a conference call to discuss its results at 1:30 p.m. PT/4:30 p.m. ET.

Link:
Skye Bioscience to Announce Third Quarter 2024 Results

CLEVELAND, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

See more here:
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced its participation in upcoming investor conferences. Presentation details with President and Chief Executive Officer, Mark Velleca, M.D., Ph.D., are as follows:

More here:
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced it will report its financial results from the third quarter ended September 30, 2024, before the financial markets open on Wednesday, November 6, 2024.

Originally posted here:
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024